Esmail, Sagira A.

HRN: 09-97-98  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2025
CEFTRIAXONE 1G (VIAL)
08/12/2025
08/18/2025
IV
2 Grams
IV OD
Uti
Remove - Pending Acceptance
08/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/12/2025
08/19/2025
IV
500
Q8
AMOEBIC DYSENTERY
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: